UFC® EXTENDS LONGSTANDING COMMITMENT TO CLEVELAND CLINIC’S PROFESSIONAL ATHLETES BRAIN HEALTH STUDY
UFC Provides $1 Million Contribution to Fund Research for the Next Five Years
Study Examines Effect of Head Impacts on Long-term Brain Health
Memphis-UFC®, the world’s premier mixed martial arts organization, today announced a five-year extension of its longstanding collaboration with Cleveland Clinic and its continued support of the Professional Athletes Brain Health Study.
This multi-year commitment, which is supported by a $1 million contribution to the Lou Ruvo Center for Brain Health in Las Vegas, ensures that research will continue to help determine the long-term effects of repetitive head trauma and factors that put certain individuals at higher risk of developing chronic traumatic encephalopathy (CTE). Since joining the landmark study in 2011, UFC has committed more than $2 million via three rounds of financial support.
Now entering its 10th year, this study – led by Cleveland Clinic’s Charles Bernick, M.D., and Aaron Ritter, M.D. – is the largest of professional athletes exposed to repetitive head trauma and the first to include retired and active male and female fighters concurrently.
“UFC is proud to continue its support of both Cleveland Clinic and the Professional Athletes Brain Health Study,” UFC Chief Operating Officer Lawrence Epstein said. “UFC has supported this study since its inception, and we take pride in standing at the forefront of helping set new standards for athlete health and safety in all sports. Dr. Bernick and Dr. Ritter are doing an amazing job, and we look forward to helping them advance their research.”
The Professional Athletes Brain Health Study (formerly the Professional Fighters Brain Health Study) was established in 2011 to examine the cumulative effects of repetitive concussive and sub-concussive impacts to the brain in a group of professional fighters. The study has since expanded to include athletes in other sports exposed to repetitive head impacts (RHI), including professional bull riders. Information from this project will help guide new policies and practices that can improve brain health in sports and others exposed to RHI in military or civilian populations.
“The support provided by UFC has been fundamental to the success of the study, allowing us to reach this 10-year milestone in our research,” said Dr. Bernick, founder and primary investigator of the Professional Athletes Brain Health Study. “Not only has their financial commitment helped to sustain the infrastructure needed for this ongoing project, the encouragement they have given fighters to participate and the expertise they have offered in regards to mixed martial arts has been invaluable.”
UFC’s commitment to aid in the funding of the Professional Athletes Brain Health Study is provided in conjunction with other organizations in the combat sports industry and facilitates ongoing progress in answering critical questions regarding the long-term effects of exposure to RHI that affect both athletes competing in sports and active-duty military personnel.
To date, the Professional Athletes Brain Health Study has enrolled more than 800 active and retired athletes. Participation is voluntary. Athletes in the study receive free, ongoing assessments of brain health and function, including MRI scans. Individual tests are repeated annually for a minimum of four years.
The longer an athlete is assessed, the more valuable information will be amassed. However, during the past 10 years, researchers have detected subtle effects of RHI on brain structure and proteins released in the blood following impact. These changes can be measured over time and may be early indicators of brain injury, bringing researchers one step closer to helping athletes proactively make informed decisions about their careers based on personal brain health data. Additionally, as CTE researchers nationwide prepare to begin clinical trials, the Repetitive Head Impact Composite Score developed from data in the study will be critical in determining the effectiveness of new therapies.
As the study embarks on the next decade of research, investigators will focus on social determinants to better understand how one’s environment impacts the onset of CTE pathology, as well as the role of neuroinflammation within the brain in the immediate aftermath of head trauma.
“Exposure to repetitive head trauma puts a person at risk for the development of cognitive changes that may occur years after an athlete has retired,” said Dr. Ritter, co-primary investigator of the Professional Athletes Brain Health Study. “The science coming out of the Professional Athletes Brain Health Study is clearly showing us that not all individuals experience cognitive changes and each individual may be affected in different ways.
“Our study is unique because we are attempting to look at all of these factors — whether they are genetic, inflammatory, based on the number of fights, time between fights, etc.— simultaneously to determine which are most important in keeping an athlete’s brain healthy. The key for the next 10 years is to discover which factors are most crucial in each individual. The Professional Athletes Brain Health Study is the largest and longest-lasting study to look at this issue. Without the support of the UFC, a study like this would never happen.”
UFC® is the world’s premier mixed martial arts organization (MMA), with more than 318 million fans and 126 million social media followers. The organization produces more than 40 live events annually in some of the most prestigious arenas around the world, while broadcasting to nearly one billion TV households across more than 171 countries. UFC’s athlete roster features the world’s best MMA athletes representing more than 72 countries. The organization’s digital offerings include UFC FIGHT PASS®, one of the world’s leading streaming services for combat sports. UFC was acquired in 2016 by global entertainment, sports and content company Endeavor, along with strategic investors Silver Lake Partners and KKR. UFC is headquartered in Las Vegas, Nevada.
For more information, visit www.UFC.com and follow UFC at
www.Facebook.com/UFC , Twitter, Snapchat and Instagram: @UFC.
About Cleveland Clinic
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S. News & World Report consistently names Cleveland Clinic
as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey. Among Cleveland Clinic’s 67,554 employees worldwide are more than 4,520 salaried physicians and researchers, and 17,000 registered nurses and advanced practice providers, representing 140
medical specialties and subspecialties. Cleveland Clinic is a 6,026-bed health system that includes a 165-acre main campus near downtown Cleveland, 18 hospitals, more than 220 outpatient facilities, and locations in southeast Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2019, there were 9.8 million total outpatient visits, 309,000 hospital admissions and observations, and 255,000 surgical cases throughout
Cleveland Clinic’s health system. Patients came for treatment from every state and 185 countries.
Visit us at clevelandclinic.org.
News and resources available at www.newsroom.clevelandclinic.org .
About the Lou Ruvo Center for Brain Health Cleveland Clinic
Lou Ruvo Center for Brain Health, which opened in 2009, provides expert diagnosis and treatment for individuals and families living with Alzheimer’s disease, Lewy body,
frontotemporal and other dementias; Parkinson’s and Huntington’s disease, multiple system atrophy and other movement disorders; and multiple sclerosis. With locations in Cleveland, OH;
Weston, Florida and headquarters in Las Vegas, Nevada, the center offers a continuum of care with no-cost opportunities for the community to participate in education and research, including disease prevention studies and clinical trials of promising new medications. An integrated entity,
Keep Memory Alive, raises funds exclusively in support of the Nevada